DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

被引:293
作者
Marzi, A
Gramberg, T
Simmons, G
Moller, P
Rennekamp, AJ
Krumbiegel, M
Geier, M
Eisemann, J
Turza, N
Saunier, B
Steinkasserer, A
Becker, S
Bates, P
Hofmann, H
Pöhlmann, S
机构
[1] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Dept Dermatol, D-91054 Erlangen, Germany
[4] Univ Marburg, Inst Virol, D-3550 Marburg, Germany
[5] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA
[6] Ohio Univ, Coll Osteopath Med, Athens, OH 45701 USA
[7] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA
关键词
D O I
10.1128/JVI.78.21.12090-12095.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The lectins DC-SIGN and DC-SIGNR can augment viral infection; however, the range of pathogens interacting with these attachment factors is incompletely defined. Here we show that DC-SIGN and DC-SIGNR enhance infection mediated by the glycoprotein (GP) of Marburg virus (MARV) and the S protein of severe acute respiratory syndrome coronavirus and might promote viral dissemination. SIGNR1, a murine DC-SIGN homologue, also enhanced infection driven by MARV and Ebola virus GP and could be targeted to assess the role of attachment factors in filovirus infection in vivo.
引用
收藏
页码:12090 / 12095
页数:6
相关论文
共 67 条
[11]   SEQUENCE AND EXPRESSION OF A MEMBRANE-ASSOCIATED C-TYPE LECTIN THAT EXHIBITS CD4-INDEPENDENT BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN-GP120 [J].
CURTIS, BM ;
SCHARNOWSKE, S ;
WATSON, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8356-8360
[12]   Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways [J].
Ding, YQ ;
He, L ;
Zhang, QL ;
Huang, ZX ;
Che, XY ;
Hou, JL ;
Wang, HJ ;
Shen, H ;
Qiu, LW ;
Li, ZG ;
Geng, J ;
Cai, JJ ;
Han, HX ;
Li, X ;
Kang, W ;
Weng, DS ;
Liang, P ;
Jiang, SB .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :622-630
[13]   The clinical pathology of severe acute respiratory syndrome (SARS): a report from China [J].
Ding, YQ ;
Wang, HJ ;
Shen, H ;
Li, ZG ;
Geng, J ;
Han, HX ;
Cai, JJ ;
Li, X ;
Kang, W ;
Weng, DS ;
Lu, YD ;
Wu, DH ;
He, L ;
Yao, KT .
JOURNAL OF PATHOLOGY, 2003, 200 (03) :282-289
[14]  
Duan Zhong-ping, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P493
[15]   Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR [J].
Feinberg, H ;
Mitchell, DA ;
Drickamer, K ;
Weis, WI .
SCIENCE, 2001, 294 (5549) :2163-2166
[16]   L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus [J].
Gardner, JP ;
Durso, RJ ;
Arrigale, RR ;
Donovan, GP ;
Maddon, PJ ;
Dragic, T ;
Olson, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) :4498-4503
[17]   Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo [J].
Geijtenbeek, TBH ;
Groot, PC ;
Nolte, MA ;
van Vliet, SJ ;
Gangaram-Panday, ST ;
van Duijnhoven, GCF ;
Kraal, G ;
van Oosterhout, AJM ;
van Kooyk, Y .
BLOOD, 2002, 100 (08) :2908-2916
[18]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[19]   Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection [J].
Geisbert, TW ;
Hensley, LE ;
Larsen, T ;
Young, HA ;
Reed, DS ;
Geisbert, JB ;
Scott, DP ;
Kagan, E ;
Jahrling, PB ;
Davis, KJ .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (06) :2347-2370
[20]   Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection [J].
Halary, F ;
Amara, A ;
Lortat-Jacob, H ;
Messerle, M ;
Delaunay, T ;
Houlès, C ;
Fieschi, F ;
Arenzana-Seisdedos, F ;
Moreau, JF ;
Déchanet-Merville, J .
IMMUNITY, 2002, 17 (05) :653-664